Introduction: Adiponectin is adipocytokin with anti-inflammatory and anti-atherogenic effects. However, studies examining the relationship between adiponectin and cardiovascular diseases have shown inconsistent results.

Aims: The aim of this study was to evaluate the plasma levels of adiponectin in clinically asymptomatic subjects with various dyslipidemic phenotypes. The associations between adiponectin and risk factors for atherosclerosis, markers of insulin resistance, and the intima-media thickness of the common carotid artery (IMT) were also evaluated.

Fee Notificationfrom 1st March 2015:The Editorial Board would like to remind submitting authors that Biomedical Papers is a publication of Palacký University and is in no way funded by the pharmaceutical industry. For this reason, from the 1st March 2015 the fee of 10.000 Czech crowns (or an equivalent sum in Euro) will apply to all manuscripts accepted for publication. Accepted manuscripts will not proceed further without receipt of payment. Thank you for your understanding. Please note, however, reviews, minireviews, commentaries and Letters to the Editor will remain free of charge.

Information For AuthorsManuscripts should be written in good and clear English. Please have your text proofread by a native English speaker before you submit it for consideration.
If you need assistance with translation/manuscript preparation in English, suitable for international journals before submission for review, please contact the proof reader
Dr. Alexander Oulton
(dub2015@seznam.cz)